This is the synthesis article — the practical protocol for applying the science in the IQ Healthspan library to a coherent, prioritized, evidence-based personal longevity framework. It organizes the interventions by evidence strength and impact, structures them into a practical daily and annual rhythm, and provides the decision framework for determining what to add, when, and in what order.
The preceding 79 articles in the IQ Healthspan library have covered the mechanisms, evidence, and specific protocols for every major domain of longevity science. This article synthesizes that material into a practical, prioritized framework for applying it. The framework is organized by evidence strength and practical impact — beginning with what every adult can and should do, and progressing through evidence-graded additions based on individual circumstances and goals.1
Not all longevity interventions are equally supported by evidence or equally impactful per unit of effort and cost. The framework has three tiers: Foundation interventions have decades of human outcome data, large effect sizes, and near-zero risk — they apply to everyone regardless of current health status or goals. Optimization interventions have strong but more targeted evidence — they are appropriate for most health-oriented adults once the foundation is established. Experimental interventions have compelling mechanistic rationale and preliminary human data but lack the definitive human outcome trials that would establish them as standard recommendations. They require physician involvement and informed consent.
Sleep: 7.5 to 9 hours per night, stable schedule. The most actionable single longevity intervention for most adults. Target consistent bed and wake times within 30 minutes of each other every day. Optimize sleep architecture by keeping the bedroom cool (65-68°F), dark, and quiet. Avoid alcohol within 3 hours of bed. Identify and treat sleep apnea if suspected. Review sleep hygiene before adding any sleep supplement.2
Aerobic exercise: 3 to 4 hours of Zone 2 per week. The most evidence-backed longevity intervention available. Build to 3 to 4 hours per week of Zone 2 aerobic training (conversation-test intensity) distributed across 3 to 5 sessions. Add 1 to 2 VO2 max interval sessions (Norwegian 4x4 or equivalent) per week. Track VO2 max annually as the primary fitness longevity biomarker.
Resistance training: 2 to 3 sessions per week. Non-negotiable for muscle mass, bone density, insulin sensitivity, and myokine secretion. Focus on compound movements that load multiple muscle groups (squat, deadlift, press, row, carry). Progress load over time. Track grip strength annually as the simplest longevity-relevant strength biomarker.3
Diet: whole-food, plant-forward, protein-adequate. Eliminate ultra-processed food and added sugar. Build meals around vegetables, legumes, quality protein sources, nuts, seeds, and olive oil. Target 1.6 to 2.2 g/kg/day of protein distributed across 3 to 4 meals. Concentrate eating earlier in the day and extend the overnight fast to 12 to 14 hours minimum.
Lifestyle foundations: Complete tobacco cessation. Alcohol minimization (if any, keep below 3 drinks/week and never within 3 hours of bedtime). Active social connection with genuine relationships. Stress management through regular aerobic exercise, adequate sleep, and deliberate recovery practices.
| Biomarker | Target | Primary Intervention if Abnormal |
|---|---|---|
| ApoB | <70 mg/dL | Dietary fat modification, statin, ezetimibe, PCSK9i |
| Blood pressure | <120/80 mmHg | Exercise, sodium reduction, medication if needed |
| Fasting insulin | <7 uIU/mL | Carbohydrate quality, Zone 2 exercise, TRE |
| hsCRP | <1.0 mg/dL | Anti-inflammatory diet, exercise, omega-3, sleep |
| 25-OH Vitamin D | 40-60 ng/mL | Vitamin D3 supplementation + K2 |
| Omega-3 index | >8% | 2-3 g EPA+DHA/day from fish or supplement |
| Homocysteine | <9 umol/L | Methylfolate + methylcobalamin B12 + B6 |
Creatine monohydrate: 5 g/day. One of the most evidence-backed supplements for muscle, cognitive function, and resistance training adaptation. No meaningful downside in healthy adults. Take at any time with food. Magnesium glycinate or malate: 300 to 400 mg elemental magnesium per day. Corrects widespread deficiency with measurable effects on sleep quality, insulin sensitivity, and cardiovascular risk. Omega-3 (EPA+DHA): Target omega-3 index above 8 percent — test before supplementing to know current level and dose accordingly. Typically 1 to 3 g EPA+DHA/day for most adults with typical fish intake.4
Hormonal deficiency correction: TRT for men with confirmed hypogonadism; HRT for women within 10 years of menopause without contraindications. These are not optional enhancements — they are corrections of deficiency states with substantial longevity implications when deficiency is present. Epigenetic age testing annually for biological age trajectory tracking. DEXA body composition and bone density baseline and annual tracking. VO2 max testing and progressive improvement targeting 75th percentile for age and sex.
Intermittent rapamycin (2-6 mg/week): compelling animal data, zero human longevity RCT evidence. Requires physician supervision, regular bloodwork monitoring, and full informed consent regarding the evidence gap. Appropriate for adults who have maximized the foundation and optimization tiers and are seeking experimental interventions. NMN/NR supplementation (500-1000 mg/day): raises NAD+, promising metabolic data, incomplete outcome evidence. Reasonable risk-benefit in adults with established foundation. Senolytics (D+Q, fisetin): Phase 2 human biological activity data, Phase 3 outcome trials pending. Consider only after foundation is established and ideally within a clinical trial context if available.5
Annual comprehensive bloodwork (complete panel from article 1.9) and physician review. Annual DEXA body composition and bone density. Annual VO2 max assessment. Annual grip strength measurement. Annual epigenetic age test (TruDiagnostic or equivalent). Annual review of all medications and supplements against current evidence. Semi-annual dental care (oral inflammation independently predicts cardiovascular risk). Regular cancer screening per USPSTF guidelines appropriate for age and risk factors.
